| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/04/2007 | US20070004681 Methods for treating arthritic conditions |
| 01/04/2007 | US20070004680 Compositions and methods for modulating gated ion channels |
| 01/04/2007 | US20070004679 Androgen receptor modulators and methods of treating disease using the same |
| 01/04/2007 | US20070004678 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes |
| 01/04/2007 | US20070004677 purinergic receptor antagonists such as N-(2-(2-tert-butylphenoxy)pyridin-3-yl)cinnamamide, used for modulation of platelet reactivity; anticoagulants |
| 01/04/2007 | US20070004676 lactam fermentation products; pyrrolooxetanediones or pyrrolothietanediones especially containing a cyclohexane; based on marine microorganisms structures; cytotoxicity, NF- kappa B inhibition, and caspase-like and trypsin-like proteasome inhibition |
| 01/04/2007 | US20070004675 Inhibitors of VEGF receptor and HGF receptor signaling |
| 01/04/2007 | US20070004674 Remedy for diseases associated with immunoglobulin gene translocation |
| 01/04/2007 | US20070004673 Administration of enoxaparin sodium to patients with severe renal impairment |
| 01/04/2007 | US20070004672 Long lasting alginate dry eye, related methods of manufacture and methods of use |
| 01/04/2007 | US20070004671 Stable desloratadine compositions |
| 01/04/2007 | US20070004670 Compositions containing citicoline, and methods of use thereof |
| 01/04/2007 | US20070004669 Mono-, di- or trifluoromethyl derivatives, e.g., 6-amino-9-(2-C-fluoromethyl- beta -D-ribofuranosyl)purine, 2'-C-(fluoromethyl)-5-methylcytidine and 2-amino-9-(2-C-fluoromethyl- beta -D-ribofuranosyl)-3,9-dihydropurin-6-thione; used to treat a hepatitis C virus infection |
| 01/04/2007 | US20070004668 Antisense permeation enhancers |
| 01/04/2007 | US20070004660 Synergistic Modulation of Flt3 Kinase Using Alkylquinolines and Alkylquinazolines |
| 01/04/2007 | US20070004659 Method for preventing or delaying the onset of diabetes |
| 01/04/2007 | US20070004657 Diagnosis and treatment of kidney fibrosis and other fibrotic diseases |
| 01/04/2007 | US20070004654 Chimeric toll-like receptor (TLR) ligand, agonist; tumor necrosis factor agonists/antagonists; Crohn's Disease; ulcerative colitis |
| 01/04/2007 | US20070004653 Stable lyophilized anthracycline glycosides |
| 01/04/2007 | US20070004652 Treatment of occlusive thrombosis |
| 01/04/2007 | US20070004651 Active ingredient combinations of one or more isoflavonoids and carnitine and/or one or more acyl-carnitines |
| 01/04/2007 | US20070004650 Endurance improving agent |
| 01/04/2007 | US20070004649 Anti-influenza virus compound comprising biflavonoid-sialic acid glycoside |
| 01/04/2007 | US20070004648 Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 01/04/2007 | US20070004647 Proteasome inhibitors and uses thereof |
| 01/04/2007 | US20070004645 Aromatic amides as potentiators of bioefficacy of anti-infective drugs |
| 01/04/2007 | US20070004644 For oral administration; atherosclerosis; cardiovascular diseases |
| 01/04/2007 | US20070004639 Methods and compositions for treating Parkinson's disease |
| 01/04/2007 | US20070004630 Treating cell proliferation disease; aberrant fetoplacental growth; cancer |
| 01/04/2007 | US20070004627 Compounds and methods for treatment of cancer |
| 01/04/2007 | US20070004626 treating osteoporosis caused by imbalance of osteoclast and osteoblast activity, glandular disorders with a Syk kinase inhibitor a 2,4-pyrimidinediamine compound; alendronate, calcitonin, estrogen and selective estrogen receptor modulators; side effect reduction |
| 01/04/2007 | US20070004624 Methods for modulating bone tissue formation, orthogenic agents and pharmaceutical compositions |
| 01/04/2007 | US20070004623 Use of hydroxylated amino acids for treating diabetes |
| 01/04/2007 | US20070004620 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus |
| 01/04/2007 | US20070004596 Biofilm growth prevention |
| 01/04/2007 | US20070004011 Phenylpropanoids from lilac flowers for drug,nutritional and cosmetic uses; stabilized cell lines with highantioxidant capacity; oxidative stress relieving; verbascoside/ isoverbascoside as wound healing agents; culture of plant cell line to a thermal enzyme deactivating treatment; industrial scale |
| 01/04/2007 | US20070003987 Screening method for substance binding to merozoite surface protein-1/42 |
| 01/04/2007 | US20070003963 RNA sequence-specific mediators of RNA interference |
| 01/04/2007 | US20070003962 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003961 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003960 Producing knockdown cells; Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003646 Administering a hops extract that includes from 75 wt % to 99.5 wt % of alpha acid and from 0.5 wt % to 10 wt % of beta acid; particularly beneficial for treating osteoarthritis and rheumatoid arthritis, and can be used for chronic pain with reduced gastric side-effects. |
| 01/04/2007 | US20070003645 Butyrospermum-triterpene fraction containing lupeol; alpha -amyrin and/or beta amyrin, and butyrospermol; plant extract |
| 01/04/2007 | US20070003642 Composition containing high concentration of isoflavone and having high solubility and process for producing the same |
| 01/04/2007 | US20070003641 Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease |
| 01/04/2007 | US20070003639 Preparation for oral administration containing physiologically active fatty acids and oligomer proanthocyanidin |
| 01/04/2007 | US20070003636 Statins (HMG-COA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 01/04/2007 | US20070003630 Anti-angiogenic compositions and methods of use |
| 01/04/2007 | US20070003629 Anticancer agents; prevent forming blood vessels; removal blockage |
| 01/04/2007 | US20070003627 Hemorrhoidal compositions and method of use |
| 01/04/2007 | US20070003623 Formulations of conjugated estrogens and bazedoxifene |
| 01/04/2007 | US20070003621 Dosage forms for movement disorder treatment |
| 01/04/2007 | US20070003620 Morphine sulfate microgranules, method for preparing same and compositions containing same |
| 01/04/2007 | US20070003617 Morphine controlled release system |
| 01/04/2007 | US20070003616 Process for the production of an abuse-proofed dosage form |
| 01/04/2007 | US20070003615 Nanoparticulate clopidogrel and aspirin combination formulations |
| 01/04/2007 | US20070003614 Pharmaceutical compositions comprising active vitamin D compounds |
| 01/04/2007 | US20070003610 Application of lipid vehicles and use for drug delivery |
| 01/04/2007 | US20070003608 Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
| 01/04/2007 | US20070003600 Methods for reducing c-reactive protein |
| 01/04/2007 | US20070003597 Polymerized and modified rapamycins and their use in coating medical prostheses |
| 01/04/2007 | US20070003596 Drug depot for parenteral, in particular intravascular, drug release |
| 01/04/2007 | US20070003593 Bone paste |
| 01/04/2007 | US20070003590 Methods of Treating Microbial Infections |
| 01/04/2007 | US20070003589 Coatings for implantable medical devices containing attractants for endothelial cells |
| 01/04/2007 | US20070003585 Topical skin treating compositions |
| 01/04/2007 | US20070003580 Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
| 01/04/2007 | US20070003571 Modified herpes simplex viral particle for targeting and destroying tumor cells |
| 01/04/2007 | US20070003564 Diluent for immunohistochemistry |
| 01/04/2007 | US20070003557 Method for treating cancer using premedication |
| 01/04/2007 | US20070003553 Anticoagulant agents useful in treatment of thrombosis |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 01/04/2007 | US20070003538 Antimicrobial compositions and uses thereof |
| 01/04/2007 | US20070003536 Using a grapefruit, grape seed and green tea extract comprising superoxide dismutase, glutathione, tetrahydrodiferuloylmethane, flavonoid, tocopherol and tocopheryl acetate as part of lotion to treat and prevent damaged skin |
| 01/04/2007 | US20070003531 Methods for improving immunotherapy by enhancing survival of antigen-specific cytotoxic T lymphocytes |
| 01/04/2007 | US20070003527 Method for enhancing leukocyte immune function |
| 01/04/2007 | US20070003524 Targeted retrograde gene delivery to motor neurons |
| 01/04/2007 | US20070003516 Compounds, compositions and methods for the treatment of poxvirus infections |
| 01/04/2007 | US20070003513 Polymerized and modified rapamycins and their use in coating medical prostheses |
| 01/04/2007 | US20070003512 Bisphosphonate resinates |
| 01/04/2007 | US20070003508 Methods and compositions for promoting wound healing |
| 01/04/2007 | US20070003505 Treatment with hyaluronic acid |
| 01/04/2007 | US20070003504 Method of enhanced benzoyl peroxide application |
| 01/04/2007 | US20070003502 Skin preparation for external use characterized by containing sugar derivative of alpha, alpha-trehalose |
| 01/04/2007 | US20070003492 Porous silica having substance carried thereon |
| 01/04/2007 | US20070003487 Composition, method and pharmaceutical preparation for pharmaceutical spray suspensions |
| 01/04/2007 | DE202006012481U1 Composition for treating or preventing cardiovascular diseases, especially atherosclerosis, comprises folate |
| 01/04/2007 | DE202005012510U1 Topical composition for regenerating cartilage tissue or joint lubrication comprises emu oil, hyaluronic acid and vitamin K1 |
| 01/04/2007 | DE112004002408T5 Verfahren zur Gewinnung einer angereicherten Population von siRNA-exprimierenden Zellen A process for obtaining an enriched population of siRNA-expressing cells |
| 01/04/2007 | DE112004002099T5 Anionen bindende Polymere und Verwendungen davon Anion-binding polymers and uses thereof |
| 01/04/2007 | DE102005030733A1 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonist and at least one other active ingredient |
| 01/04/2007 | DE102005030522A1 Salz des Embusartans Salt of the Embusartans |
| 01/04/2007 | DE102005030423A1 Neue Formulierung für Vecuroniumbromid New formulation of vecuronium bromide |
| 01/04/2007 | DE102005030294A1 Nichtsteroidale Progesteronrezeptor-Modulatoren Non-steroidal progesterone receptor modulators |
| 01/04/2007 | DE102005030293A1 Verwendung von nichtsteroidale Progesteronrezeptor-Modulatoren Use of nonsteroidal progesterone receptor modulators |
| 01/04/2007 | DE102005029390A1 Wirkstoffkombinationen aus Glycopyrroniumbromid und Polyolen Active compound combinations of glycopyrronium and polyols |
| 01/04/2007 | DE102005029389A1 Wirkstoffkombinationen aus Glycopyrroniumbromid und dialkylsubstituierten Essigsäuren Active compound combinations of glycopyrronium and dialkyl substituted acetic acids |
| 01/04/2007 | DE102005029372A1 Selektive Hemmstoffe humaner corticoidsynthasen Selective inhibitors of human corticoidsynthasen |
| 01/04/2007 | DE102005028937A1 Verfahren zur Herstellung von Dronabinol Process for preparing dronabinol |
| 01/04/2007 | CA2667449A1 Hiv-1 protease inhibitors, and methods of making and using them |